[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100421820":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":22,"responsibleParty":38,"collaborators":7,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":43,"sex":49,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":55,"studyType":56,"phases":7,"briefSummary":57,"conditions":58,"keywords":62,"overallStatus":24,"whyStopped":7,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Amsterdam UMC, location VUmc","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Paul Knaapen, Professor","Amsterdam University Medical Centers, Department of Cardiology","PRINCIPAL_INVESTIGATOR",[14,18],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},"CONTACT","+31 20 444 0123","p.knaapen@amsterdamumc.nl",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"Ruben de Winter, MD","+ 31 20 444 0381","r.dewinter1@amsterdamumc.nl",[23],{"facility":11,"status":24,"city":25,"state":7,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Amsterdam","1081 HV","Netherlands","NL",{"type":30,"coordinates":31},"Point",[32,33],4.88969,52.37403,{"lat":33,"lon":32},[36],{"name":19,"role":15,"phone":20,"phoneExt":7,"email":37},"R.dewinter1@amsterdamumc.nl",{"type":12,"investigatorFullName":39,"investigatorTitle":40,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Paul Knaapen","Principle investigator, MD, PhD, Professor of Cardiac Intervention and Imaging","100421820","prior-cabg-patients-evaluated-for-saphenous-vein-graft-dysfunction-and-progression-of-coronary-artery-disease-100421820",false,"NCT04772768","Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease","Patients With Prior Coronary Artery Bypass Graft Surgery Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease","VIADUCT","Inclusion Criteria:\n\n* Prior coronary artery bypass grafting\n* One or more saphenous vein grafts\n* Recurrent angina symptoms\n\nExclusion Criteria:\n\n* \\\u003C18 years of age\n* ≥ 90 years of age\n* Cardiogenic shock\n* Pregnancy\n* Failure to provide informed consent","ALL","18 Years","90 Years",{"count":53,"type":54},500,"ESTIMATED","5 Years","OBSERVATIONAL","This is a multi-center, observational cohort study including patients with prior coronary artery bypass grafting (CABG) and ≥1 saphenous vein grafts (SVG) presenting with recurrent ischemic symptoms. Objective: to investigate the clinical outcomes in patients with prior CABG evaluated for bypass graft failure and progression of native coronary artery disease (CAD). Follow-up will be collected through national registry databases, electronic medical patient records and standardized telephonic assessment at 3 and 5 years follow-up.",[59,60,61],"Recurrent Angina After Coronary Artery Bypass Graft","Graft Failure","Coronary Artery Disease Progression",[63,64,65,66],"Coronary Artery Bypass Grafting","Recurrent angina","Saphenous vein graft dysfunction","Advanced coronary artery disease","2023-05-30",{"date":69,"type":70},"2023-06-02","ACTUAL",{"date":72,"type":70},"2019-08-23",{"date":74,"type":54},"2029-07-23",{"name":5,"class":6},1]